Published December 2, 2015 | Version v1
Journal article Restricted

CartiCaroGenea®-AM: A Mesenchymal stem cells derived chondropoietic Autologous Cartilagenous Treatment for patients with cartilage defects validated of a dose warping algorithm using clinically realistic scenarios.

Authors/Creators

  • 1. Biogenea Pharmaceuticals Ltd

Description

CartiCaroGenea®-AM: A Mesenchymal stem cells derived chondropoietic Autologous Cartilagenous Treatment for patients with cartilage defects validated of a dose warping algorithm using clinically realistic scenarios.

Files

Restricted

The record is publicly accessible, but files are restricted. <a href="https://zenodo.org/account/settings/login?next=https://zenodo.org/records/34557">Log in</a> to check if you have access.